• Facet’s strategic and tactical regulatory affairs, statistics, regulatory writing, and commercialization experts lead small organizations to faster and more efficient product development, US registration, and commercial launch.
  • Facet has used statistical modeling and simulations to greatly improve clinical trial success in Phase 2 and Phase 3.
  • Facet’s regulatory experts set the strategy and lead the tactical plans to prepare and submit 3-5 US marketing applications each year.
  • Preparations for commercial launch and reimbursement are a necessary part of product development.  Even if you are not planning to take your product to US approval, a robust commercialization plan adds value to your asset and helps you communicate with potential acquirers/partners.